Pilot Study of Behavioral Activation for Prolonged Grief

December 1, 2014 updated by: Anthony Papa
The Institute of Medicine identifies Prolonged Grief (PG) as a critical under-addressed public health problem for which are no empirically supported treatments. The purpose of this application is to pilot-test Behavioral Activation (BA) therapy for PG. BA is a well supported, stand alone intervention for depression and recently applied to posttraumatic stress disorder, which reduces rumination and avoidance behaviors that otherwise thwart access to natural rewarding contingencies and resources. The treatment focuses on promoting stable, active routines, self-care behaviors, enhanced self-efficacy, and reengagement with pleasurable activities and significant social resources. Rumination, disengagement, and low self-efficacy are defining features of PG. Further, in response to loss of intimates, the key factors that differentiate resilient people from those that have difficulties adapting is the maintenance or fast resumption of social and occupational functioning. Thus, the main hypothesis of this study is that BA for PG will result in clinically significant reductions in rumination and functional disengagement. This is a preliminary small-scale pilot assessment of potential efficacy and feasibility of completing a large scale study of BA for PG.

Study Overview

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nevada
      • Reno, Nevada, United States, 89557
        • University of Nevada, Reno

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • meet criteria for Prolonged Grief Disorder
  • must be 21 years old or older
  • if taking psychotropic medication, must have been on a stable dose for three or more months prior to study entry

Exclusion Criteria:

  • presence of active suicidal or homicidal ideation
  • a history of psychotic symptoms
  • current participation in psychosocial treatment focused on grief symptoms
  • active substance abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IMMEDIATE START GROUP
Randomized to participate in Behavioral Activation for pathological grief starting at Week 1 of entry into the study
Behavioral Activation for Major Depressive Disorder (BA; Martell, Addis, & Jacobson, 2001) is based on behavioral theories of depression, which posit that psychopathology occurs when active, goal-directed behavioral repertoires have been either unreinforced or punished. These aversive consequences tend to reinforce escape and avoidance behavior, such as passively ruminating on unmet needs and/or deprivations, rather than actively engaging the environment. BA employs operant conditioning principles to increase active, goal-directed behavioral strategies and decrease passive or avoidant behavioral strategies to help people engage with and obtain adequate reinforcement from their environment. Use of BA was based research suggesting that disengagement/avoidance is related to prolonged pathology after loss
Placebo Comparator: DELAY START GROUP
Randomized to participate in Behavioral Activation for pathological grief starting at Week 12 of entry into the study
Behavioral Activation for Major Depressive Disorder (BA; Martell, Addis, & Jacobson, 2001) is based on behavioral theories of depression, which posit that psychopathology occurs when active, goal-directed behavioral repertoires have been either unreinforced or punished. These aversive consequences tend to reinforce escape and avoidance behavior, such as passively ruminating on unmet needs and/or deprivations, rather than actively engaging the environment. BA employs operant conditioning principles to increase active, goal-directed behavioral strategies and decrease passive or avoidant behavioral strategies to help people engage with and obtain adequate reinforcement from their environment. Use of BA was based research suggesting that disengagement/avoidance is related to prolonged pathology after loss

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in grief symptoms at weeks 12, 24, and 36 post randomization
Time Frame: Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
Inventory of Complicated Grief-Revised
Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
Change from Baseline in PTSD symptoms at weeks 12, 24, and 36 post randomization
Time Frame: Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
PTSD Checklist-Specific
Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
Change from Baseline in symptoms of Major Depressive Disorder at Weeks 12, 24, and 36 post randomization
Time Frame: Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
Depression Anxiety Stress Scales
Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in levels of rumination at Weeks 12, 24, and 36 post randomization
Time Frame: Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
Ruminative Response Scale
Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
Therapy credibility and client expectancy for improvement after treatment
Time Frame: Assessments occurring post-treatment (12 weeks for immediate start group, 24 weeks for delay start group)
Credibility/ Expectancy Questionnaire
Assessments occurring post-treatment (12 weeks for immediate start group, 24 weeks for delay start group)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Antony Papa, Ph.D., University of Nevada, Reno

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2009

Primary Completion (Actual)

May 1, 2012

Study Completion (Actual)

May 1, 2012

Study Registration Dates

First Submitted

March 12, 2012

First Submitted That Met QC Criteria

March 14, 2012

First Posted (Estimate)

March 16, 2012

Study Record Updates

Last Update Posted (Estimate)

December 2, 2014

Last Update Submitted That Met QC Criteria

December 1, 2014

Last Verified

December 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Depressive Disorder

Clinical Trials on Behavioral Activation

Subscribe